Vital Signs - Desire to Control Costs Drives Usage of Topical Hemostats and Tissue Sealants
Vital Signs - Desire to Control Costs Drives Usage of Topical Hemostats and Tissue Sealants
RELEASE DATE
17-Dec-2007
17-Dec-2007
REGION
North America
North America
Research Code: 9561-00-50-00-00
SKU: HC00511-NA-MR_03983
$1,500.00
In stock
SKU
HC00511-NA-MR_03983
Description
This issue of Vital Signs, released on December 17, 2007, provides a strategic overview the Topical Hemostats and Tissue Sealants market. Additionally, a company spotlight is provided for Angiotech Pharmaceuticals, a specialty pharmaceutical and medical device company that develops, manufactures and markets advanced technologies and medical products for local diseases, complications associates with medical device implants, surgical interventions and acute injury. Reimbursement and regulatory news from the FDA is also provided for the week of December 3 - December 7, 2007.
Table of Contents
This week's issue:
Popular Topics
This issue of Vital Signs, released on December 17, 2007, provides a strategic overview the Topical Hemostats and Tissue Sealants market. Additionally, a company spotlight is provided for Angiotech Pharmaceuticals, a specialty pharmaceutical and medical device company that develops, manufactures and markets advanced technologies and medical products for local diseases, complications associates with medical device implants, surgical interventions and acute injury. Reimbursement and regulatory news from the FDA is also provided for the week of December 3 - December 7, 2007.
No Index | Yes |
---|---|
Podcast | No |
Industries | Healthcare |
WIP Number | 9561-00-50-00-00 |
Is Prebook | No |